Skip to main content
SpringerLink
Log in

Reverse transcription-polymerase chain reaction (RT-PCR) assays of estrogen and progesterone receptors in breast cancer

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

The biochemical assay for estrogen (ER) and progesterone receptors (PR) as a routine procedure in the clinical evaluation of human breast cancer is well established. Since there are various and complex phenotypic alterations in breast cancer, there is a need for a multiparametric assessment of the biological profile of breast tumours. However, multiparametric analysis requires a large amount of tissue and various methods of quantitative analysis involving expensive reagents. Thus, an evaluation of the diagnostic and prognostic applications of the measurement of mRNA expression by reverse transcription polymerase chain reaction (RT-PCR) has been initiated. A series of 105 surgical samples of breast cancer was assayed for ER and PR expression in parallel by semi-quantitative RT-PCR and standardized enzymoimmunoassays (EIA). 79 (75%) tumour samples were positive for ER expression by EIA, and 86 (82%) by RT-PCR. This shows a good concordance of the two methods (90%). In the case of PR expression 65 (62%) tumour samples were positive by EIA and only 53 (51%) samples by RT-PCR. In conclusion ER-RT-PCR appears to provide information concerning ER expression similar to ER-EIA, and may be an alternative to this assay. The information derived by PR-RT-PCR appears somewhat different from PR-EIA. We are currently evaluating the biological and clinical significance of this discrepancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Osborne CK, Yochmowitz MG, Knight WA III, McGuire WL: The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46: 2884–2888, 1980

    PubMed  Google Scholar 

  2. Wenger CR, Beardslee S, Owens MA, Pouds G, Oldaker T, Vendely P, Pandian MR, Harrington D, Clark GM, McGuire WL: DNA ploidy, S-phase, and steroid receptors in more than 127000 breast cancer patients. Breast Cancer Res Treat 28: 9–20, 1993

    PubMed  Google Scholar 

  3. Foekens JA, Peters HA, Portengen H, Noordegraaf E, Berns EM, Klijn JGM: Cell biological prognostic factors in breast cancer: a review. J Clin Immunoassay 14: 184–195, 1991

    Google Scholar 

  4. Dall P, Heider KH, Sinn HP, Skroch-Angel P, Adolf G, Kaufmann M, Heerlich P, Ponta H: Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer 60: 471–477, 1995

    PubMed  Google Scholar 

  5. Jänicke F, Schmitt M, Pache L, Ulm K, Harbeck N, Höfler H, Graeff H: Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res Treat 24: 195–208, 1993

    PubMed  Google Scholar 

  6. Chevillard S, Pouillart P, Beldjord C, Asselain B, Beuzeboc P, Magdelénat H, Vielh P: Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy. Cancer 77: 292–300, 1996

    PubMed  Google Scholar 

  7. Dutrillaux B, Gerbault-Sereau M, Remvikos Y, Zafrani B, Prieur M: Breast cancer genetic evolution: I. Data from cytogenetics and DNA content. Breast Cancer Res Treat 19: 245–255, 1991

    PubMed  Google Scholar 

  8. Blankenstein MA: Comparison of ligand binding assay and enzymoimmunoassay of estrogen receptor in human breast cancer cytosols. Experience of the EORTC Receptor Study Group. Breast Cancer Res Treat 17: 91–98, 1990

    PubMed  Google Scholar 

  9. Fiszer-Szafarz B, Szafarz D, Guevara de Murilla A: A general, fast and sensitive micromethod for DNA determination. Anal Biochem 110: 165–170, 1981

    PubMed  Google Scholar 

  10. Ponglikitmonkol M, Green S, Chambon P: Genomic organization of the human estrogen receptor gene. EMBO J 7: 3385–3388, 1988

    PubMed  Google Scholar 

  11. Misrahi M, Venencie PY, Saugier-Veber P, Sar S, Dessen P, Milgrom E: Structure of the human progesterone receptor gene. Biochem Biophys Acta 1216: 289–292, 1993

    PubMed  Google Scholar 

  12. Romain S, Lainé Bidron C, Martin PM, Magdelénat H on behalf of the EORTC Receptor Study Group: Steroid receptor distribution in 47892 breast cancers. A collaborative study of 7 European laboratories. Eur J Cancer 31A: 411–417, 1995

    PubMed  Google Scholar 

  13. McGuire WL: Breast cancer prognostic factors: Evaluation guidelines. J Natl Cancer Inst 83: 154–155, 1991

    PubMed  Google Scholar 

  14. McGuire WL, De la Garza M, Chamness GC: Evaluation of estrogen receptor assays in human breast cancer tissue. Cancer Res 37: 637–639, 1977

    PubMed  Google Scholar 

  15. May E, Mouriesse H, May-Levin F, Contesso G, Delarue JC: A new approach allowing an early prognosis in breast cancer: the ratio of estrogen receptor (ER) ligand binding activity to the ER-specific mRNA level. Oncogene 4: 1037–1042, 1989

    Google Scholar 

  16. Fuqua SAW, Falette NF, McGuire WL: Sensitive detection of estrogen receptor RNA by polymerase chain reaction assay. J Natl Cancer Inst 82: 858–860, 1990

    PubMed  Google Scholar 

  17. Nagai MA, Marques LA, Yamamoto L, Fujiyama CT, Brentani MM: Estrogen and progesterone receptor mRNA levels in primary breast cancer: association with patient survival and other clinical and tumor features. Int J Cancer 59: 351–356, 1994

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire de Transfert, Institut Curie, 26 rue d'Ulm, 75231, Paris Cédex 5, France

    S. Chevillard, C. Levalois & H. Magdelénat

  2. Département de Pathologie, Institut Curie, 26 rue d'Ulm, 75231, Paris, Cédex 5, France

    A. Müller, C. Lainé-Bidron, Ph. Vielh & H. Magdelénat

Authors
  1. S. Chevillard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Levalois
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Lainé-Bidron
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ph. Vielh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Magdelénat
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chevillard, S., Müller, A., Levalois, C. et al. Reverse transcription-polymerase chain reaction (RT-PCR) assays of estrogen and progesterone receptors in breast cancer. Breast Cancer Res Tr 41, 81–89 (1996). https://doi.org/10.1007/BF01807039

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01807039

Key words

Search

Navigation